Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Hydrogen peroxide/ATR-Chk2 activation mediates p53 protein stabilization and anti-cancer activity of cheliensisin A in human cancer cells.

Authors: Zhang, Jingjie; Gao, Guangxun; Chen, Liang; Li, Jingxia; Deng, Xu; Zhao, Qin-shi; Huang, Chuanshu

Published In Oncotarget, (2014 Feb 15)

Abstract: Chiliensisine A (Chel A) as a novel styryl-lactone isolated from Goniothalamus cheliensis Hu has been indicated to be a chemotherapeutic agent in Leukemia HL-60 cells. However, its potential for cancer treatment and the underlying mechanisms are not deeply investigated to the best of our knowledge. Current studies showed that Chel A could trigger p53-mediated apoptosis, accompanied with dramatically inhibition of anchorage-independent growth of human colon cancer HCT116 cells. Further studies found that Chel A treatment resulted in p53 protein stabilization and accumulation via the induction of its phosphorylation at Ser20 and Ser15. Moreover, Chel A-induced p53 protein accumulation and activation required ATR/Chk2 axis, which is distinct from the mechanism that we have most recently identified the Chk1/p53-dependent apoptotic response by Chel A in normal mouse epidermal Cl41 cells. In addition, our results demonstrated that hydrogen peroxide generation induced by Chel A acted as a precursor for all these signaling events and downstream biological effects. Taken together, we have identified the Chel A as a new therapeutic agent, which highlights its potential for cancer therapeutic effect.

PubMed ID: 24553354 Exiting the NIEHS site

MeSH Terms: Apoptosis/drug effects; Ataxia Telangiectasia Mutated Proteins/genetics; Ataxia Telangiectasia Mutated Proteins/metabolism; Checkpoint Kinase 2/genetics; Checkpoint Kinase 2/metabolism*; Colonic Neoplasms/drug therapy*; Colonic Neoplasms/metabolism; Colonic Neoplasms/pathology; Epoxy Compounds/pharmacology*; HCT116 Cells; Humans; Hydrogen Peroxide/metabolism*; Pyrones/pharmacology*; Signal Transduction; Transfection; Tumor Suppressor Protein p53/genetics; Tumor Suppressor Protein p53/metabolism*; Tumor Suppressor Proteins/genetics; Tumor Suppressor Proteins/metabolism

to Top